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Background: Glucocorticoid receptor (GR) is essential for early phase of adipogenesis.
Results:Depletion of coregulatorCCAR1 compromised adipogenesis in cell culture andGR-mediated chromatin remodeling of
peroxisome proliferator-activated receptor (PPAR) gene enhancer elements.
Conclusion: GR and CCAR1 are required for transcriptional activation of PPAR and adipocyte differentiation.
Significance: Mechanistic analysis identifies specific critical roles for GR and coregulator CCAR1 in the early stages of
adipogenesis.
Glucocorticoids contribute to adipocyte differentiation by
cooperating with transcription factors, such as CCAAT/en-
hancer-binding protein  (C/EBP), to stimulate transcription
of the gene encoding peroxisome proliferator-activated recep-
tor (PPAR), a master regulator of adipogenesis. However, the
mechanism of PPAR gene regulation by glucocorticoids, the
glucocorticoid receptor (GR), and its coregulators is poorly
understood. Here we show that two GR binding regions (GBRs)
in the mouse PPAR gene were responsive to glucocorticoid,
and treatment of 3T3-L1 preadipocytes with glucocorticoid
alone induced GR occupancy and chromatin remodeling at
PPAR GBRs, which also contain binding sites for C/EBP and
PPARproteins.GR recruited cell cycle and apoptosis regulator
1 (CCAR1), a transcription coregulator, to the PPAR gene
GBRs. Notably, CCAR1 was required for GR occupancy and
chromatin remodeling at one of the PPAR gene GBRs. More-
over, depletion of CCAR1 markedly suppressed differentiation
of mouse mesenchymal stem cells and 3T3-L1 preadipocytes to
mature adipocytes and decreased induction of PPAR, C/EBP,
and C/EBP. Although CCAR1 was required for stimulation of
several GR-regulated adipogenic genes in 3T3-L1 preadipocytes
by glucocorticoid, it was not required for GR-activated tran-
scription of certain anti-inflammatory genes in human A549
lung epithelial cells. Overall, our results highlighted the novel
and specific roles of GR and CCAR1 in adipogenesis.
Obesity is a major risk factor for many diseases, such as type
2 diabetes, hypertension, and cardiovascular disease (1). Hence,
it is recognized as a prevalent health hazard worldwide. This
excess of white adipose tissue caused by increases in the size
and number of white adipocytes is the major cause of obesity.
The number of white adipocytes present in an organism is
determined largely by adipocyte differentiation (1). Therefore,
elucidation of mechanisms of adipocyte differentiation is
essential for understanding the pathogenesis of obesity and
obesity-related diseases and thereby providing important infor-
mation for developing new strategies to prevent and treat
obesity.
Adipocytes, themajor fat-containing components of adipose
tissue, are developed from mesenchymal stem cells (MSC)3 in
adipose tissue. This process involves an initial commitment
phase where MSC are committed to the preadipocyte lineage
followed by a differentiation phase (adipogenesis) where pre-
adipocytes differentiate into mature fat-laden adipocytes. The
major discoveries of key adipogenic signaling pathways have
relied heavily on investigations in preadipocyte cell lines, such
as mouse 3T3-L1 cells, which undergo a highly conserved and
efficient program of adipogenesis in culture and upon trans-
plantation in vivo (2). Because subsequent experiments in mice
have convincingly validated the physiological significance of
these major signaling pathways, the in vitro differentiation
model represents a powerful and valid tool for deciphering the
complex regulatory network of adipocyte differentiation.
The adipogenic conversion of most mouse and human pre-
adipocyte cell lines requires stimulation with a hormonal mix-
ture that consists of the synthetic glucocorticoid analogue dexa-
methasone (dex), insulin, and the cAMP phosphodiesterase
inhibitor isobutylmethylxanthine (IBMX). Temporary expo-
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sure of preadipocytes to the adipogenic stimuli induces a com-
plex network of pro-adipogenic transcription factors that act at
different stages of differentiation and cooperatively promote
adipogenesis. Significant players in this transcriptional cas-
cade include CCAAT/enhancer binding protein (C/EBP)
family members (i.e. C/EBP, C/EBP, and C/EBP) and the
nuclear receptor peroxisome proliferator-activated receptor 
(PPAR), which is considered as the master positive regulator
of preadipocyte differentiation to adipocytes and is both indis-
pensable and under some conditions sufficient for adipogenesis
(2). The expression levels of C/EBP and C/EBP are low in
preadipocytes but are greatly enhanced after treatment of the
cells with adipogenic mixture. During the first hour of adipo-
genesis, both of these C/EBPs associate with regulatory ele-
ments of a variety of adipogenic genes, including the twomajor
late-acting transcription factors, C/EBP and PPAR, and sub-
sequently activate gene expression. Raised levels ofC/EBP and
PPAR then induce each other’s expression in a positive feed-
back loop promoting andmaintaining the differentiated state of
the mature adipocyte (3).
Dex is a key component of the adipogenic mixture and is
involved in transcriptional regulation of adipogenesis via
binding to and activating the glucocorticoid receptor (GR), a
hormone-dependent transcription factor (4). Several lines of
evidence have demonstrated the important role of GR in
adipogenesis. First, cells with decreased GR levels were unable
to efficiently store lipids and express adipocyte-selective pro-
teins C/EBP and PPAR in response to adipogenic stimuli.
Second,GR is involved in induction of key pro-adipogenic tran-
scription factor C/EBP (4) as well as several other adipogenic
genes such as RGS2 (5) and EPAS1 (6). Finally, during the early
stages of adipogenesis, transient enrichment of GR, C/EBP,
mediator subunit 1 (Med1), p300, and histone acetylation at
regulatory sites near adipogenic genes has been previously
reported (7); target genes include the gene encoding themaster
regulator of adipogenesis, PPAR. Thus, GR cooperates with
C/EBP to initiate transcriptional activation of key adipogenic
genes that are required to specify adipogenic cell fate. However,
both the precise molecular contribution by GR and the identi-
ties of the transcriptional coregulators that support and modu-
late GR activity during the adipocyte differentiation process
remain largely unexplored and are the subject of the study pre-
sented here.
In addition to the role of glucocorticoids and GR in regu-
lating adipogenesis, glucocorticoids are well known for their
anti-inflammatory and immunosuppressive properties and
are, therefore, widely and successfully used in the treatment of
numerous inflammatory conditions, including autoimmune
diseases, inflammatory bowel disease, and lymphoma. Never-
theless, glucocorticoids are also infamous for adversemetabolic
side effects associatedwith the chronic administration required
to treat these diseases effectively. For approximately two
decades, great efforts have been made to identify and develop
for clinical use selective GR ligands that dissociate beneficial
anti-inflammatory effects from adverse metabolic effects of
glucocorticoids (8–11), but unfortunately with little success.
Another possible approach to this problem may be offered by
coregulators, which have been shown to function in a gene-
specific manner with GR and other transcription factors and,
therefore, may represent potential targets for combination
therapy to accompany the use of classical anti-inflammatory
steroids such as dex. For example, inhibition of a coregulator
required for regulation of genes involved in the metabolic
actions of glucocorticoids but not required for regulation of
genes involved in the anti-inflammatory response to glucocor-
ticoids could limit some side effects associated with glucocor-
ticoid treatment of inflammatory diseases.
Toward that end we performed a limited screen of coregula-
tors by assessing the effect of depleting each coregulator from
3T3-L1 cells on the induction of several adipogenic genes by
dex. In parallel, we tested the effect of coregulator depletion on
dex-induced expression of several anti-inflammatory genes in
A549 human lung adenocarcinoma cells. From this screen cell
cycle and apoptosis regulator 1 (CCAR1), previously identified
as a coactivator for GR (12), was preferentially required for
dex-induced expression of adipogenic genes versus anti-inflam-
matory genes. Subsequently, we characterized the role of
CCAR1 in the differentiation of 3T3-L1 cells to mature adi-
pocytes and themechanisms bywhichGR andCCAR1 contrib-
ute to the activation of the key adipogenic transcription factor,
PPAR. We found that CCAR1 determines adipogenic compe-
tency, acting in part through positive regulation of GR tran-
scriptional activity that drives early adipogenesis. Thus, target-
ing glucocorticoid coregulators, such as CCAR1, could be an
effective approach to separate beneficial anti-inflammatory
effects of glucocorticoids from certain unfavorable effects of
glucocorticoids, such as obesity involving aberrantly activated
adipogenesis.
EXPERIMENTAL PROCEDURES
Materials—Antibodies against the following proteins were
purchased and used for this study: GR from Santa Cruz Bio-
technology;-actin and-tubulin fromSigma;CCAR1 and IgG
from Bethyl Laboratory. Secondary antibodies (horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG) were
purchased from Promega. Insulin, dex, and IBMX were pur-
chased from Sigma. Transfection reagent Dharmafect Duo was
purchased from Thermo Fisher Scientific-Dharmacon, and
Oligofectamine was purchased from Invitrogen.
Lentivirus-mediated Coregulator Depletion—For lentivirus
production, the packaging vector pCMV-R8.91, the envelop
plasmid pMD.G1, and the transfer vector pHRCMVpuroSin8
targeting nonspecific sequence as control were described pre-
viously (13). For depletion of mouse CCAR1, two pLKO.1 vec-
tors expressing shRNA against different regions of CCAR1
mRNAwere purchased from Sigma. Lentiviral particle produc-
tion and virus transduction were performed according to a pre-
viously described protocol (13).
Cell Cultures and RNA Interference Screen—A549 human
lung carcinoma cells weremaintained in DMEMwith 10% fetal
bovine serum (FBS). 3T3-L1 mouse preadipocyte cells were
maintained in DMEM supplemented with 10% bovine calf
serum. For coregulator depletion in 3T3-L1 cells, siRNA was
transfected into the detached 3T3-L1 cells in suspension by
using DharmaFECT duo as mentioned previously (14) or
Hiperfect (Qiagen). The siRNA-cell mixture was plated and
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incubated at 37 °Cwith 5%CO2 for 2 days before themedia was
exchanged for phenol-red free DMEM supplemented with 5%
charcoal-stripped FBS. The next day, cells were treated with
100 nM dex or ethanol as control for 6 h. For coregulator deple-
tion in A549 cells, siRNA was transfected into attached cells by
using Oligofectamine or Hiperfect (Qiagen) according to the
manufacturer’s protocol. Two days after transfection, the
mediumwas changed to phenol red-free DMEMcontaining 5%
charcoal-stripped FBS. The sequences of the sense siRNA used
were as follows: nonspecific control siRNA (15); si-mBAF57
(Santa Cruz, sc-45941); si-mCARM1, 5-GCCAUGAAGAU-
GUGUGUGU-3; si-mCCAR1, 5-GCUACAUGAUACAU-
UUGGATT-3; si-mCoCoA, 5-CCUUGCGGGAAUAGAAU-
UATT-3; si-mDBC1, 5-AUGACUAUGACUCGAAGAATT-3;
si-mFli-I, 5-CACATTCAGTCTTCAGAAGAA-3; si-mMed14
(Santa Cruz, sc-142586); si-mTIF1 (Santa Cruz, sc-38549);
si-mTip60, 5-CGGAGUAUGACUGCAAAGGTT-3; si-
mZNF282 (Santa Cruz, sc-108045); si-hBAF57, 5-AAC-
CGCGTACCTTGCTTACAT-3; si-hCARM1 (15); si-hCCAR1
(12); si-hCoCoA (16); si-hDBC1 (17); si-hFli-I, 5-AACAAC-
CTGACCACGCTTCAT-3; si-hMed14 (Santa Cruz, sc-38579);
si-hTip60 (18); si-hTIF1 (19); si-hZNF282, 5-AATTTGG-
GAACCACATGGAGA-3.
Differentiation into Adipocytes—For induction of differenti-
ation with adipogenic mixture, 3T3-L1 cells were grown for an
additional 2 days after confluence, and the 2-day post-confluent
cells (designated as day 0) were induced to differentiate with
DMEM containing 10% FBS, 0.5 mM IBMX, 1 M dex, and 1
g/ml insulin. After 2 days, medium was changed with fresh
DMEM containing 10% FBS and again every other day thereaf-
ter until processing for analysis. Mouse MSC derived from the
bone marrow of C57BL/6 mice were obtained from Cyagen
Biosciences. MSC were cultured in OriCell mMSC growth
medium (Cyagen Biosciences) and differentiated into adi-
pocytes according to manufacturer’s instructions. Briefly, 3
days after MSC reached confluence, MSC were induced to dif-
ferentiatewith adipogenicmediumcontaining FBS, IBMX, dex,
insulin, and rosiglitazone (a PPAR agonist). After cells had
differentiated, acquisition of adipocyte phenotype was deter-
mined by Oil Red O staining as described previously (4).
Chromatin Immunoprecipitation (ChIP)—Two days after
3T3-L1 cells reached confluence, culture medium was
removed, and cells were grown in DMEM supplemented
with 5% charcoal-stripped FBS overnight. The next day, cells
were treatedwith orwithout 100 nMdex for the indicated times.
ChIP assays were carried out as described previously (20). For
immunoprecipitation, 8 g of CCAR1 antibodies, 4 g of anti-
bodies against GR, or 4 g of normal rabbit IgG were used.
Purified immunoprecipitated DNA and input DNA were used
as the template for amplification by quantitative PCR with
the following primer pairs: 5-AGCTTTGCTGGCTAGAG-
GTG-3 (forward) and 5-TTTCGCAGAACTGAGGTTGA-3
(reverse) (183 kb relative to the PPAR2 transcription start
site (TSS)) (7) and 5-TTCTTCCCAGTAGGAACTGCAT-3
(forward) and 5-GATCACTCAGTTGGCATTTCTC (reverse)
(10 kb relative to PPAR2 TSS) (7). After amplification, a
melting curve analysis was performed to confirm the homoge-
neity of PCRproducts fromeach reaction. The immunoprecipi-
tated DNA and input signals were quantified using the relative
standard curve method, and results were expressed as the per-
centage of input by normalizing the immunoprecipitated signal
to its corresponding input signal.
Formaldehyde-assisted Isolation of Regulatory Elements
(FAIRE) Assays—3T3-L1 cells were grown with culture
medium for an additional 2 days after confluence and were
incubated with phenol-red free DMEM containing 5% char-
coal-stripped FBS overnight. Cells were then treated with or
without 100 nM dex for 90 min, and subsequently cells were
cross-linked with 1% formaldehyde and prepared for FAIRE
analysis. FAIRE was performed essentially as previously
described (21). In brief, nuclei were isolated from harvested
cells and submitted to sonication to shear chromatin. Samples
were subjected to phenol/chloroform/isoamyl alcohol extrac-
tion to recover free DNA not bound by nucleosomes in the
aqueous phase. After extraction cross-linkingwas reversed, and
the FAIRE DNAs were purified. Input chromatin samples were
obtained before the phenol/chloroform/isoamyl alcohol
extraction, and DNA was purified as described above. Repre-
sentation of specific GR binding sites in the FAIRE DNA sam-
ples (which represent open chromatin regions) was determined
relative to input DNA by quantitative PCR using the same PCR
primers specified above for ChIP.
Quantitative Reverse Transcriptase-PCR—RNA was extracted
from cells using the TRIzol method (Invitrogen), resuspended in
diethylpyrocarbonate-treated H2O, and adjusted to 100 ng/l.
cDNA was synthesized by reverse-transcribing 0.9 g of total
RNA using iScript cDNA synthesis kit (Bio-Rad). The cDNA
wasmixedwith appropriate primers and LightCycler 480 SYBR
Green I Master (Roche Applied Science), and the mixture was
then analyzed with the LightCycler 480 System (Roche Applied
Science). The primers used are listed in Table 1 or as follows:
mC/EBP, mC/EBP, mC/EBP, and mGlut4 (4); h-actin
(20); hGilz (12); hDUSP1 (22), hCARM1 (23), hCCAR1 (12),
hCoCoA (16), hDBC1 (17), hTip60 (18), and hZNF282 (24).
Results shown are mean and range of variation for duplicate
PCR reactions from a single cDNA preparation and are repre-
sentative of a minimum of two independent experiments. Rel-
ative mRNA expression levels were determined by normalizing
against GAPDH for mouse mRNA and -actin for human
mRNA.
Plasmids, Transfection, and Luciferase Reporter Assay—GR
binding regions (GBRs) 1 and 2 from mouse PPAR gene were
amplified by Expand Long Template PCR System (Roche
Applied Science) from mouse genomic DNA using the follow-
ing primers: GBR1_5, GCTGCAGGTACCGCAGAGGAC-
CAGGTAGGTC; GBR1_3, CGCTCTCTCGAGCTCTGGC-
CTTAATGTCCTGT; GBR2_5, GCTGCAGGTACCCCAA-
CGCATGCAAGTCTTAC; GBR2_3, CGCTCTCTCGAGC-
AGTGGGTATTCCTAACTGC. These PCR fragments were
cloned into the pGL4.10-E4TATAvectorwithKpnI/XhoI sites.
pGL4.10-E4TATA reporter plasmidwas generated by insertion
of a 50-bp minimal E4 TATA promoter sequence (25) into the
BglII to HindIII sites of vector pGL4.10 to drive luciferase ex-
pression (26). Lipofectamine 2000 (Invitrogen) was used to
transfect 3T3-L1 preadipocytes according to the technical
manual. Twenty-four hours post-transfection cells were
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treated with either 1 M dex or control ETOH for 16–20 h.
Cells were then harvested, and their luciferase activities were
measured with the Dual Luciferase Reporter Assay kit
(Promega) according to procedures in the technical manual.
RESULTS
Identification of GRCoregulators Involved in Adipogenic Ver-
sus Anti-inflammatory Gene Transcription—GR belongs to the
steroid hormone receptor subclass of nuclear receptors and
controls physiological processes through activation or repres-
sion of distinct sets of causative target genes driving different
physiological pathways. Previous studies reported that coregu-
lators function in a gene-specific manner. We then tried to
define coregulator utilization patterns by performing a limited
RNA interference screen. Ten different coregulators were indi-
vidually down-regulated by transfection of cells with small
interfering RNA (siRNA) to investigate their involvement in
glucocorticoid-induced expression of five adipogenic genes
in 3T3-L1 preadipocytes and three anti-inflammatory genes in
A549 lung carcinoma cells (Fig. 1). ThemRNA levels of coregu-
lators were substantially reduced by their respective siRNAs
when compared with nonspecific siRNA (Fig. 1A). In agree-
ment with previous studies, gene-specific coregulator require-
mentswere observed (Fig. 1B).Moreover, coregulatorsCCAR1,
CARM1, DBC1, and Tip60 are required for optimum dex-in-
duced expression of the selected adipogenic genes but not for dex-
induced expression of the selected anti-inflammatory genes (Fig.
1B). Hence,we propose that single coregulators or specific combi-
nations of coregulators may dictate specific glucocorticoid-con-
trolled biological functions by selectively regulating important
causative genes in distinct physiological pathways.
CCAR1 Is Required for Adipogenesis—Our siRNA screen
indicated that CCAR1 is important for the expression of adipo-
genic genes. This result prompted us to examine the require-
ment of CCAR1 in adipocyte differentiation using short hairpin
RNA (shRNA)-mediated knockdown. Adipose-derived MSC
from C57BL/6 mice were infected with lentivirus encoding
shRNAagainst CCAR1 (shCCAR1) or against a nonspecific tar-
FIGURE 1. Effect of depletion of endogenous coregulators on the expres-
sion of GR-regulated adipogenic genes or anti-inflammatory genes. A,
human A549 or mouse 3T3-L1 cells were transfected with control siNS or
siRNA specific for each coregulator listed and grown in culture media for 2
days. The culture media were replaced with hormone-free media overnight,
and the cells were treated with 100 nM dex or control ETOH for 6 h before
harvesting. Total RNA was analyzed by quantitative real-time-PCR to deter-
mine the relativemRNA level for each coregulator in the cells transfectedwith
siNS or siRNA against the coregulator. The coregulatormRNA expressionwas
normalized to the level of human -actin mRNA in A549 cells or mouse
GAPDH mRNA in 3T3-L1 cells. For each experiment, the control nonspecific
(NS) signal was set to 100, and the relative mRNA expression of the specific
coregulator was calculated by dividing the si-coregulator signal by the siNS
signal followed bymultiplying by 100. Data are themeans S.E. B, total RNA
was analyzed for each target gene mRNA by quantitative real-time-PCR and
normalized to the level of human -actin mRNA in A549 cells or mouse
GAPDH mRNA in 3T3-L1 cells. Colors represent degree of change in dex-in-
duced expression level after depletion of the indicated coregulator. The color
code is shownon thebottom. Results shownare representative of at least two
independent experiments.
TABLE 1
Primer sequences for RT-PCR
m-, mouse; h-, human.
Gene Forward primer sequence (533) Reverse primer sequence (533)
mBAF57 GGAATCGTAATGCCAGAGGA ACACCAGGGTTTGTGGGATA
mCARM1 ATCGCCCTCTACAGCCATGA CTGTCTGCCCACACGACTG
mCCAR1 ATTGCCCACAAGCCTTAGCC TGTAGCTTTGTAACCACTCCTGT
mCoCoA CAAGGTGGAATGTCACTACACTT CGTGTGATAATCTCGAACGCAG
mDBC1 TTTAAGCGGCAGAGGATCAAC GGAGGAGTAAGTAGACCAGGG
mFli-I GGACGATGTGTTGACAGTGG CTGCCGAGGTAGGAAGAGTG
mMed14 TTATTTGTGGATACCGCTGA CAATCGCATATGGAATAGCA
mTIF1 GTTGTCTATGATGTGTCTCTCAGC GGTGGTCCTTCGCCATTC
mTip60 AGACACCTACCAAGAACGGAC GTGTGATCTGGACCGGGATTG
mZNF282 AGCAATGTCGACGAAGGTCA TGGAGAACCTGGAGAACCTG
mEpas1 ATCACGGGATTTCTCCTTCC GGTTAAGGAACCCAGGTGCT
mRgs2 CTTTTCTTGCCAGTTTTGGG GAGGAGAAGCGGGAGAAAAT
mSphk1 TGCAGTTGATGAGCAGGTCT ACCCCTGTGTAGCCTCCCT
mLpin1 TGAAGACTCGCTGTGAATGG CGCCAAAGAATAACCTGGAA
mPPAR2 CGCTGATGCACTGCCTATGA AATGGCATCTCTGTGTCAACCA
mGAPDH ATCCATGACAACTTTGGCATT ATGACCTTGCCCACAGCCTT
hBAF57 GGGGTTTTGGAATCGTGATA CACCAGGGTTTGTGGGATAC
hFli-I ACAAGTGTTCCACCTTCTGC CTCAGCGGCAACGACTTC
hMed14 AAGCCATCCTGTTTGTGGAC GCATATGGGATGGCAAAACT
hTIF1 CAAACCCAATGGACCAGTTC TGGCTTTATTGCTTGTCGTG
hZFP36 GAGAACTTGGAGAACTTGCTGCGC GTAGTTCTCCTTAACAAGGTTGTT
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get (shNS) as control. Efficient depletion of CCAR1 proteinwas
achieved by two different shRNAs directed against different
regions of the CCAR1mRNA (Fig. 2A). CCAR1-depletedMSC
and the control culture expressing shNS were induced to dif-
ferentiate with adipogenic stimuli containing dex, insulin,
IBMX, and rosiglitazone (a PPAR agonist); the differentiation
efficiency was determined 3 weeks later by Oil Red O staining.
The control culture underwent efficient differentiation to lipid
droplet-containing adipocytes (Fig. 2B). In contrast, differenti-
ation efficiency of CCAR1-depleted MSC was drastically
reduced. Thus, CCAR1 depletion suppressed adipocyte differ-
entiation, suggesting that CCAR1 is essential for adipogenesis.
Many discoveries of key adipogenic events, signaling pathways,
and transcriptional controlmechanisms have been based on stud-
ies in cell lines derived frommouse embryonic fibroblasts, partic-
ularly the 3T3-L1 cell line. Importantly, given that most of the
findings from cell lines have been convincingly validated in vivo,
the invitro3T3-L1differentiationmodel represents avaluable tool
for identification of novelmolecules and signaling networks regu-
lating adipogenesis.Whenwe infected3T3-L1cellswith lentivirus
encoding shNSor twodifferent species of shCCAR1,CCAR1pro-
tein levels were specifically reduced in cells expressing CCAR1
shRNA, but not in cells expressing shNS (Fig. 2C). Aswe observed
for the MSC, shCCAR1 greatly decreased the efficiency of adipo-
genesis, as assessed byOil RedOdye staining after 8 days of treat-
ment with adipogenic stimuli containing dex, insulin, and IBMX
(Fig. 2D). These results demonstrate the critical involvement of
CCAR1 in adipocyte differentiation.
CCAR1Functions inAdipogenesis at an Early Stage of 3T3-L1
Adipocyte Differentiation—We further analyzed the expression
of adipocyte-specific markers at various time points after add-
ing adipogenic stimuli to 3T3-L1 cells expressing shCCAR1 or
control shNS. In particular, we examined the expression of key
adipogenic transcription factors that are induced during adipo-
genesis, including PPAR. Two different mRNAs are produced
from two different TSSs of the PPAR gene; because the
PPAR2 TSS is themajor isoform induced during adipogenesis
(27), we specifically examined transcripts produced from this
TSS. CCAR1 protein levels remained depleted by shCCAR1
throughout the adipogenesis process (Fig. 3A). As a conse-
quence of CCAR1 knockdown, induction of mRNA expression
for terminal differentiationmarkers (e.g. PPAR2 and C/EBP)
by the adipogenic mixture was greatly reduced (Fig. 3B). Expres-
sionofGlut4 (glucose transporter 4), the insulin-regulated glucose
FIGURE 2. Depletion of CCAR1 blocks adipogenesis. A and B, MSC were
infected with lentiviral vectors expressing shRNA against CCAR1 or nonspe-
cific (NS) sequence and subsequently differentiated with complete differen-
tiation media. A, immunoblot verifying depletion of CCAR1 protein level at
the start of thedifferentiationprocess.B, Oil RedO stainingof cells expressing
the indicated shRNA and differentiated in completed differentiation media
for 3 weeks. Results are representative of a minimum of two independent
experiments.C andD, 3T3-L1 cellswere transducedwith lentivirus expressing
shRNAs targeting either CCAR1or a nonspecific sequence as control. Infected
cells were selected with puromycin and subsequently were replated at con-
fluent cell density. After 2 days the cells were induced to differentiate. C, cells
were harvested at the beginning of differentiation, and cell lysates were sep-
arated by SDS-PAGE and analyzed by immunoblot with antibodies against
CCAR1 or -actin protein.D, cells were stained with Oil Red O to visualize the
accumulation of lipid droplets at day 8 of differentiation. Results are repre-
sentative of a minimum of two independent experiments.
FIGURE3.Timecourseofadipogenicgeneexpression in3T3-L1cells afterCCAR1depletion.A, immunoblot analysis of theCCAR1protein expression from
3T3-L1 cells infected with lentivirus expressing control (NS) or CCAR1 shRNAs and subsequently treated with adipogenic mixture. Day 2, sub-confluent
growing cells before differentiation induction; day 0, confluent cells at time of induction with differentiation mixture; days 3–8, time after the addition of
adipogenicmixture. B, quantitative real-time PCR analysis of total RNAduring differentiation of 3T3-L1 preadipocytes. Cells were treated as inA. Results shown
are normalized to the level of GAPDHmRNA, are themean and range of variation for duplicate PCR reactions from a single experiment, and are representative
of three independent experiments.
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transporter that is found inmature adipose tissues, was also inhib-
ited by down-regulation of CCAR1 (Fig. 3B). For early adipocyte-
specificmarkersCCAR1depletionmoderately reduced the induc-
tion of C/EBP but had little or no effect on induction of C/EBP
(Fig. 3B).Thus,CCAR1 functions early in adipogenesis to facilitate
induction of C/EBP, PPAR2, and C/EBP.
Both Major Regulatory Elements of the PPAR Gene Confer
Glucocorticoid Response—During the process of adipocyte dif-
ferentiation, PPAR expression is strongly induced, and subse-
quently PPAR is directly involved in the activation of most
adipocyte genes. Hence, PPAR is recognized as the master
regulator of adipogenesis (28). Within hours of initiation of
adipogenesis, GR is activated by dex, and expression of early
adipogenic transcription factors C/EBP and C/EBP is
induced; all three transcription factors occupy key PPAR gene
regulatory elements and remodel local chromatin structure.
Chromatin remodeling facilitates enhanced transcription fac-
tor binding and recruitment of coregulators and basal tran-
scription machinery, including RNA polymerase II, ultimately
resulting in gene transcription. Thus, the importance ofGR and
the C/EBP proteins for induction of PPAR expression by adi-
pogenic mixture has been addressed. However, the specific
molecular roles of GR and its associated coregulators in PPAR
gene activation are not known.
Two important regulatory elements for controlling PPAR
gene expression have been reported (7). TheGBRswithin the reg-
ulatory elements of PPAR gene are located at 183 kb (GBR1)
and10 kb (GBR2) upstream from the TSS of the PPAR2 pro-
moter (Fig. 4A). There are also confirmed binding sites for
C/EBP proteins and PPAR near the GBRs.
To investigate the functional role of GR in PPAR gene activa-
tion,we first testedwhether the twoGBRsare functionally respon-
sive to glucocorticoids. We inserted GBR1 (chr6: 115238568-
115238963) or GBR2 (chr6: 115412360-115412835) into reporter
plasmid pGL4.10-E4TATA encoding firefly luciferase. The
reporter plasmids were transfected into 3T3-L1 cells, and the
cells were then treated with dex alone for 16–20 h before har-
vesting. Luciferase expression from both reporters was dex-
responsive (Fig. 4B), indicating that both GBRs confer gluco-
corticoid-directed transcriptional responses.
Next, to focus on the mechanism by which GR regulates
PPAR gene activation, 3T3-L1 preadipocytes were treated
with dex alone instead of the full adipogenic mixture. Using
FAIREs assays to assess chromatin accessibility, we observed
that treatment of 3T3-L1 cells with dex alone for only 90 min
was sufficient to induce significant chromatin opening as well
as significant GR occupancy at both PPARGBRs (Fig. 5). This
FIGURE 4. Twomajor regulatory elements of the PPAR gene confer glu-
cocorticoid regulation. A, genomic locations of two PPAR regulatory ele-
ments. The PPAR gene contains two major regulatory sites containing
closely associated binding sites for GR, C/EBP proteins, and PPAR itself. The
GBRs are located at 183 kb (GBR1) and 10 kb (GBR2) upstream from the
PPAR2 gene TSS. B, GBR1 (chr6: 115238568-115238963) or GBR2 (chr6:
115412360-115412835) was inserted into reporter plasmid pGL4.10-E4TATA
encoding firefly luciferase reporter. The reporter plasmids were transfected
into 3T3-L1 cells, and cells were then treated with dex or vehicle for 16–20 h
before harvesting. Cells lysates were prepared and subjected to luciferase
assay. Data are the means  S.E. Results shown are representative of three
independent experiments.
FIGURE5.Dex-inducedchromatin remodelingandtranscriptioncomplex
assemblyatGBRsof thePPARgene.3T3-L1 cells confluent for 2dayswere
incubated with charcoal-stripped medium overnight and then treated with
100 nM dex for 90 min. Cells were harvested for FAIRE (A) or ChIP (B) assays
performed as described under “Experimental Procedures.” Quantitative PCR
analyses were performed using primers specific for the PPAR gene enhanc-
ers. Results shown are percentage of input, are the mean and range of varia-
tion for duplicate PCR reactions from a single experiment, and are represen-
tative of four (for ChIP) or five (for FAIRE) independent biological replicates. p
valuewas determined fromall of the biological replicates by Student’s paired
t test. **, p 0.01.
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demonstrates thatGRdirects the opening of chromatin confor-
mation at both of the key PPAR enhancer elements.
CCAR1 Is Important for Dex-induced GR Binding and Chro-
matin Remodeling at a Key Regulatory Element Controlling
PPAR Gene Expression—Previously, CCAR1 has been shown
to interact with GR and positively regulate GR-controlled gene
expression (12). Our results show CCAR1 is required for effi-
cient induction of several adipogenic genes by dex (Fig. 1).
Furthermore, CCAR1 depletion significantly inhibited the
induction of PPAR2 gene expression (Fig. 3B) as well as adi-
pogenesis (Fig. 2) by the adipogenic mixture containing dex.
Therefore, we tested whether CCAR1 acts through GR sig-
naling to regulate the expression of PPAR2 during adi-
pocyte differentiation. In four independent ChIP experi-
ments CCAR1 was recruited to PPAR enhancer elements in
a dex-dependent manner (Fig. 5B); however, the results were
not statistically significant by Student’s paired t test, possibly
due to the relatively weak signal enrichment obtained in
ChIP experiments using antibodies against CCAR1 and
many other coregulators. Because these results were pro-
duced by a 90-min treatment with dex alone, it suggests that
CCAR1 is recruited to the PPAR enhancer elements by GR
and is thus in position to act directly on the PPAR gene to
facilitate transcriptional activation.
To investigate the mechanism of CCAR1 action on the
PPAR gene during the early hours of adipocyte differentiation,
we assessed the effect of reducedCCAR1 levels on transcription
complex assembly on the PPAR gene. Reduction of CCAR1
levels by shRNA had no measurable effect on the cellular levels
of GR (Fig. 6A). However, CCAR1 depletion significantly
reduced the ligand-dependent occupancy of GR on PPAR
GBR1 (Fig. 6B); for GBR2 a similar trend was observed but was
not significant. The result indicates that CCAR1 is required for
optimal association of GR with the GBR1 enhancer of PPAR
gene. We further assessed whether CCAR1 is involved in chro-
matin remodeling at the PPAR gene enhancer elements by
FAIRE analysis. CCAR1 depletion significantly inhibited the
hormone-induced enhancement of chromatin accessibility at
GBR1 but had only a modest (non-significant) effect on chro-
matin remodeling at GBR2 (Fig. 6C). Thus, activation of GR
alone is sufficient to initiate chromatin remodeling of the
PPAR gene, and CCAR1 is required for optimal ligand-in-
duced chromatin remodeling and optimal binding of GR to the
PPAR gene.
FIGURE 6. CCAR1 is essential for dex-induced chromatin remodeling and GR binding to the PPAR gene. 3T3-L1 cells expressing shNS or shCCAR1 and
confluent for 2 days were incubated with or without 100 nM Dex for 90min. Protein levels weremonitored by immunoblot using the indicated antibodies (A).
ChIP (B) and FAIRE (C) assayswere conducted as describedunder “Experimental Procedures.” Quantitative PCR analyseswere performedusingprimers specific
for the PPAR enhancers. Results shown are from a single experiment, which is representative of five (ChIP) or three (FAIRE) independent biological replicates.
Themeanand rangeof variationofduplicatePCR reactions fromasingleexperiment are shown. Thepvaluewasdetermined fromall of thebiological replicates
by Student’s paired t test. *, p 0.05.
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DISCUSSION
Glucocorticoids play an important role in inducing adipocyte
cell fate and differentiation both in vivo and ex vivo (29–31).
This regulatory process is critically important in normal phys-
iology and numerous disease states; patients exposed chroni-
cally to excess glucocorticoids frequently experience problems
such as increased adiposity, insulin resistance, hyperglycemia,
hyperlipidemia, muscle wasting, osteoporosis, or a variety of
other pathological conditions. The fact that coregulators func-
tion in a gene-specific manner to support transcriptional regu-
lation by GR suggests that coregulators may regulate specific
physiological pathways among the many that are targeted by
GR and glucocorticoids. Currently, the coregulators that medi-
ate or modulate gene regulation by GR during adipocyte differ-
entiation remain to be determined. In addition, although GR is
known to play a critical role in adipogenesis, other transcription
factors (e.g. three C/EBP proteins) are also required. As a result,
the precise molecular role of GR in this process is not well
understood. Thus, a better understanding of GR and coregula-
tor function and gene-specificity during the adipogenic process
will ultimately provide critical information that may advance
development of novel remedies for obesity or obesity-associ-
ated diseases, such as diabetes and hypertension.
During early adipogenesis, GR is activated by glucocorti-
coids, and expression of multiple other transcription factors,
including C/EBP and C/EBP, is activated in response to the
adipogenic signals. These transcription factors subsequently
associate with enhancer elements of key adipogenic genes (32)
including the PPAR gene, which encodes themaster regulator
of adipogenesis. By recruiting coregulators the early adipogenic
transcription factors trigger dynamic epigenetic modifications
and modulation of the chromatin landscape at the two major
PPAR enhancer elements located at10 and183 kb from
the PPAR2 TSS (28). In preadipocytes, the repressive his-
tone H3 lysine 9 dimethylation (H3K9me2) marks are found
throughout the PPAR locus, leading to transcriptional
repression (33). Within hours of adding the adipogenic mix-
ture to preadipocytes, the two upstream PPAR enhancer
elements are characterized with open chromatin configura-
tion and are enriched for active transcription marks, histone
H3 lysine 9 and 27 acetylation, replacing the previously depos-
itedH3K9me2 (33).Moreover, these regions are occupied byGR,
C/EBP, C/EBP, and other transcription factors as well as
coregulators p300 (a histone acetyltransferase) andMed1 (7, 32).
The importance of coregulators for the efficient expression
of gene sets controlling adipogenesis has started to be explored
in adipose tissue biology. For instance, SRC-2/ or SRC-3/
mice exhibit reduced weight compared with control mice, and
it was reported that this effect is at least partly due to a defect in
adipocyte differentiation and fat accumulation inwhite adipose
tissue (34, 35). At the molecular level, it has been shown that
SRC-2 acts synergistically with transcription factor PPAR
(34), whereas SRC-3 functions with C/EBP transcription fac-
tors (35). However, the coregulators that mediate the function
of GR have not been reported yet.
The fact that GR and C/EBP proteins co-occupy the PPAR
gene enhancer elements after treatment with the adipogenic
mixturemakes it difficult to assess the specific role of GR in this
process. To specifically study GR function in PPAR gene acti-
vation, 3T3-L1 preadipocytes were treated with dex alone
(without the other adipogenic stimuli). Treatment with dex for
only 90minwas sufficient to induce chromatin opening in both
enhancer regions of PPAR as well as GR occupancy (Fig. 5). At
this early time point and in the absence of the other compo-
nents of the adipogenicmixture, these results indicate that acti-
vated GR directs the early chromatin remodeling at the PPAR
enhancer elements. Furthermore, our finding that CCAR1 is
recruited to the sameGBRs in a dex-dependentmanner (Fig. 5)
and is also required for optimal chromatin remodeling at one of
these sites (Fig. 6) also implicates GR in the recruitment of
CCAR1 and in the chromatin remodeling process. Because
occupancy of C/EBP and GR on the PPAR gene enhancer
elements was previously shown to be co-dependent at a later
time point in the adipogenic process (7, 32), we cannot rule out
the possibility that a low level of C/EBP occupancy at these
sites is required to facilitate GR binding and CCAR1 recruit-
ment. Nevertheless, the activation of GR by dex is clearly the
triggering event for initiation of chromatin remodeling on the
two PPAR gene enhancer elements.
In this study we also identified CCAR1 as a novel coregulator
required for adipogenic differentiation of 3T3-L1 preadi-
pocytes and MSC (Fig. 2) and for expression of key adipogenic
genes (PPAR2, C/EBP, and C/EBP) induced by the adipo-
genic mixture in 3T3-L1 cells (Fig. 3B). Furthermore, we
showed that CCAR1, which is known to interact with and sup-
port the activity of GR in other cell lines (12), positively regu-
lates expression of a subset ofGR-mediated adipogenic genes in
a dex-dependentmanner (Fig. 1B). ChIP data demonstrated the
dex-induced occupancy of CCAR1 at the two key enhancer ele-
ments of the PPAR gene (Fig. 5B), indicating that CCAR1 can
exert its positive regulator effect directly on this gene (although
we cannot rule out the possibility that CCAR1 also acts through
an indirect mechanism). Interestingly, CCAR1 is necessary for
full dex-induced binding ofGRaswell as chromatin remodeling
at PPAR enhancer regions (Fig. 6). Although CCAR1 itself is
not known to possess chromatin remodeling activity, CCAR1
could be involved in facilitating GR interaction with or recruit-
ment of an ATP-dependent or other type of chromatin remod-
eling complex. Thus, CCAR1 acts at a very early stage of the
gene activation process to influence the occupancy of GR and
its ability to direct chromatin remodeling and subsequent
assembly of an active transcription complex on the PPAR2
promoter. This contrasts from our earlier finding for other GR
target genes in a different cell line that CCAR1 is required for
recruitment of the mediator complex and not for efficient GR
occupancy of the gene (12). These contrasting results on differ-
entGR target genes that requireCCAR1 indicate that CCAR1 is
a very versatile coregulator protein that acts in a gene-specific
manner and uses different mechanisms of action on different
target genes. Collectively, our results indicate that CCAR1 is
a key pro-adipogenic coregulator that positively regulates
adipogenic gene expression through the GR signaling path-
way and provides essential functions during the early stage of
adipogenesis.
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